(Reuters) - BEIJING | Tue Jan 10, 2012
China has ordered a halt to all unapproved stem cell treatments and clinical trials, state media reported on Tuesday, as Beijing seeks to rein in the largely untested stem cell therapies now on offer across the country.
"Health providers could no longer charge money for experimental stem cell applications"
Tuesday, January 10, 2012
Subscribe to:
Posts (Atom)
